查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507212

高血压药物市场、占有率、规模、趋势、行业分析报告：依病理学、依类型、依推进剂、依通路、依药物类型、依地区、细分市场预测，2024-2023年

Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Condition (Primary, Secondary); By Type; By Propulsion; By Distribution Channel; By Medication Type; By Region; Segment Forecast, 2024- 2023
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球高血压药物市场规模将达到346.461亿美元。本研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

高血压药物市场经历显着成长，部分原因是人们对高血压作为严重健康问题的认识不断提高，以及全球医疗保健服务的普及。这一趋势对于刺激抗高血压药物的需求非常重要。这是因为提高认识和改善获得医疗保健的机会对高血压（心血管疾病的主要危险因素）的诊断和管理有直接影响。

一般民众和医疗保健专业人员对高血压的认识显着提高。这种认知的提高是政府和非政府组织目的是防治心血管疾病的广泛公共卫生运动、教育计画以及措施的结果。这些努力提高了人们对高血压相关风险的认识，包括中风、心臟病和肾衰竭，并鼓励积极管理血压值。随着人们认识的提高，越来越多的人会寻求高血压的医疗建议，这可能直接影响抗高血压药物的需求。

医疗保健可近性在推动高血压药物市场方面的作用怎么强调也不为过。最近的趋势是，世界各地，尤其是发展中国家的医疗基础设施改善。这包括扩大医疗设施、增加医务人员数量以及引进全民健康保险。这些发展使更广泛的人群更容易获得医疗保健服务，并增加了诊断和治疗高血压的可能性。早期有效的高血压治疗可以大幅降低严重併发症和需要使用抗高血压药物的风险。

远距医疗和数位健康平台在提高医疗保健可近性方面也发挥着非常重要的作用。这些技术使偏远和服务欠缺地区的患者能够咨询医疗保健提供者、接受健康教育并管理像高血压等慢性病。远距医疗服务的便利性和高效性使得这些平台得到广泛采用，让更多的患者得到及时的诊断和处方，进一步增加了对高血压药物的需求。

此外，将高血压管理纳入初级卫生保健环境已成为改善医疗保健可近性的重要因素。初级保健医生通常是有健康问题的人的第一个接触点，可以帮助早期发现和管理高血压。透过将血压筛检纳入常规医疗就诊，医疗保健系统可以更有效地识别和治疗高血压。

高血压的全球负担是一个紧迫的公共卫生挑战，而该疾病是全球疾病负担的主要贡献者。随着社会对血压失控的影响越来越了解，并且随着医疗保健系统的发展变得更加全面和方便，对高血压药物的需求预计将会增加。对预防性保健和慢性病管理的日益重视进一步增加了对有效抗高血压药物的需求。

高血压治疗市场报告亮点

2023年，血管张力素转换酶（ACE）抑制剂领域占据高血压药物市场最大的市场占有率。它是首选的慢性治疗药物，因为它可以有效地长期控制高血压，而且没有严重的副作用。

预计零售药局业务在预测期内将以最快的年复合成长率成长。零售药局日益提供血压监测、健康检查和慢性病管理计划等服务，使其成为高血压患者的重要接触点。

2023年，北美占最大市场。北美人口老化对高血压药物市场做出了重大贡献。高血压盛行率随着年龄的成长而增加，美国人口普查局预测，到2030年，所有婴儿潮世代的年龄都将达到 65 岁或以上，这进一步增加了对高血压药物的需求。

亚太地区预计将以最快的年复合成长率成长高血压药物市场。经济成长和医疗保健支出增加：经济成长导致许多亚太国家的医疗保健支出增加。这导致对医疗基础设施的投资增加，并获得更广泛的药物，包括抗高血压药物。

全球主要市场参与者包括Takeda Pharmaceutical Company Limited.、AstraZeneca、Teva Pharmaceutical Industries Ltd、Abbott, Pfizer Inc.、Novartis AG, Merck KGaA、Johnson & Johnson Services, Inc.、Gilead Sciences, Inc.、Sanofi S.A.、Bayer AG。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球高血压药物市场洞察

  • 高血压药物 - 产业概况
  • 高血压药物市场动态
    • 推动因素和机会
      • 世界各地高血压的盛行率上升，对药物的需求预计也会增加。
      • 提高人们对高血压是严重健康问题的认识，并改善获得医疗保健服务的机会
    • 抑制因素和挑战
      • 专利到期日
  • PESTLE分析
  • 高血压药物产业的趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球高血压药物市场：依疾病状况

  • 主要发现
  • 简介
  • 原发性
  • 续发性

第6章 全球高血压药物市场：依通路

  • 主要发现
  • 简介
  • 零售药局
  • 电子商务药局
  • 医院药房

第7章 全球高血压药物市场：依类型

  • 主要发现
  • 简介
  • 利尿剂
  • α受体阻断剂
  • 钙通道阻断剂
  • β受体阻断剂
  • 血管张力素转换酶（ACE）抑制剂
  • 血管扩张剂
  • 其他

第8章 全球高血压药物市场：依药物类型

  • 主要发现
  • 简介
  • 合併治疗
  • 单一疗法
  • 固定剂量组合

第9章 全球高血压药物市场：地区

  • 主要发现
  • 简介
    • 高血压药物市场评估：依地区，2019-2032年
  • 北美
    • 北美：依疾病状态，2019-2032年
    • 北美：依药物类型，2019-2032年
    • 北美：依通路，2019-2032年
    • 北美：依类型，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依疾病状态，2019-2032年
    • 欧洲：依药物类型，2019-2032年
    • 欧洲：依通路，2019-2032年
    • 欧洲：依类型，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疾病状态，2019-2032年
    • 亚太地区：依药物类型，2019-2032年
    • 亚太地区：依通路，2019-2032年
    • 亚太地区：依类型，2019-2032年
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东与非洲：依疾病状态，2019-2032年
    • 中东和非洲：依药物类型，2019-2032年
    • 中东与非洲：依通路，2019-2032年
    • 中东、非洲：依类型，2019-2032年
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯联合大公国
  • 拉丁美洲
    • 拉丁美洲：依疾病状态，2019-2032年
    • 拉丁美洲：依药物类型，2019-2032年
    • 拉丁美洲：依通路，2019-2032年
    • 拉丁美洲：依类型，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第11章 公司简介

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd
  • Abbott
  • Pfizer Inc
  • Novartis AG
  • Merck KGaA
  • Johnson & Johnson Services, Inc
  • Gilead Sciences, Inc
  • Sanofi S.A
  • Bayer AG
Product Code: PM1331

The global hypertension drug market size is expected to reach USD 34,646.10 Million by 2032, according to a new study by Polaris Market Research. The report "Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Condition (Primary, Secondary); By Type; By Propulsion; By Distribution Channel; By Medication Type; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The hypertension drugs market is experiencing substantial growth, driven in part by the rising awareness of hypertension as a critical health issue and improved access to healthcare services worldwide. This trend is crucial in stimulating demand for antihypertensive medications, as increased awareness and healthcare access directly influence the diagnosis and management of hypertension, a major risk factor for cardiovascular diseases.

Awareness of hypertension, often referred to as high blood pressure, has significantly increased among the general population and healthcare professionals. This heightened awareness is the result of extensive public health campaigns, educational programs, and initiatives by governments and non-governmental organizations aimed at combating cardiovascular diseases. These efforts have made individuals more cognizant of the risks associated with high blood pressure, including stroke, heart attack, and kidney failure, thereby encouraging proactive management of blood pressure levels. As awareness grows, more individuals are likely to seek medical advice for hypertension, directly impacting the demand for antihypertensive drugs.

The role of healthcare access in driving the hypertension drugs market cannot be overstated. In recent years, there has been a global push towards improving healthcare infrastructure, particularly in developing countries. This includes the expansion of healthcare facilities, increased availability of healthcare professionals, and the implementation of universal health coverage schemes. Such developments have made healthcare services more accessible to a larger segment of the population, thereby increasing the likelihood of hypertension diagnosis and treatment. Early and effective management of hypertension significantly reduces the risk of developing severe complications, necessitating the use of antihypertensive medications.

Telemedicine and digital health platforms have also played a pivotal role in enhancing healthcare access. These technologies have made it possible for patients in remote or underserved areas to consult with healthcare providers, receive health education, and manage chronic conditions like hypertension. The convenience and efficiency of telehealth services have led to wider adoption of these platforms, further driving the demand for hypertension medications as more individuals receive timely diagnoses and prescriptions.

Moreover, the integration of hypertension management into primary healthcare settings has been a significant factor in improving healthcare access. Primary care practitioners are often the first point of contact for individuals with health concerns, making them instrumental in the early detection and management of hypertension. By integrating blood pressure screening into routine healthcare visits, healthcare systems can identify and treat hypertension more effectively, thereby increasing the demand for antihypertensive medications.

The global burden of hypertension is a pressing public health challenge, with the condition being a major contributor to the global disease burden. As societies become more informed about the implications of uncontrolled blood pressure and as healthcare systems evolve to become more inclusive and accessible, the demand for hypertension drugs is expected to rise. The growing emphasis on preventive healthcare and the management of chronic conditions further underscores the need for effective antihypertensive medications.

Hypertension Drug Market Report Highlights

In 2023, the angiotensin-converting enzyme (A.C.E.) inhibitors segment accounted for the largest market share in the hypertension drug market. Their efficacy in the long-term management of hypertension without significant adverse effects makes them a preferred choice for chronic therapy.

The retail pharmacies segment is expected to grow at the fastest CAGR during the forecast period. Retail pharmacies increasingly offer services such as blood pressure monitoring, health screenings, and chronic disease management programs, making them a key point of contact for hypertension patients.

In 2023, North America dominated the largest market. The aging population in North America significantly contributes to the hypertension drug market. Hypertension prevalence increases with age, and the U.S. Census Bureau projects that by 2030, all baby boomers will be age 65 or older, further increasing the demand for hypertension medications.

Asia Pacific is expected to grow at the fastest CAGR in Hypertension Drug market. Economic Growth and Rising Healthcare Expenditure: Economic growth in many Asia Pacific countries has led to increased healthcare expenditure. This allows for greater investment in healthcare infrastructure and access to a wider range of medications, including those for hypertension.

The global key market players are Takeda Pharmaceutical Company Limited., AstraZeneca, Teva Pharmaceutical Industries Ltd, Abbott, Pfizer Inc., Novartis AG, Merck KGaA, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., Sanofi S.A., Bayer AG.

Polaris Market Research has segmented the hypertension drug market repair report based on condition, type, distribution channel, medication type, and region.

Hypertension Drug, Condition Outlook (Revenue - USD Million, 2019 - 2032)

  • Primary
  • Secondary

Hypertension Drug, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Diuretics
  • Alpha-Blockers
  • Calcium Channel Blockers
  • Beta blockers
  • Angiotensin-Converting Enzyme (A.C.E.) Inhibitors
  • Vasodilators
  • Others

Hypertension Drug, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Retail Pharmacies
  • E-Commerce Pharmacies
  • Hospital Pharmacies

Hypertension Drug, Medication Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Combination Therapy
  • Monotherapy
  • Fixed Dose Combinations

Hypertension Drug, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hypertension Drug Market Insights

  • 4.1. Hypertension Drug - Industry Snapshot
  • 4.2. Hypertension Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of hypertension worldwide have been projected to spur drug demand
      • 4.2.1.2. Rising awareness of hypertension as a critical health issue and improved access to healthcare services
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Patent expirations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Hypertension Drug Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hypertension Drug Market, by Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • 5.3. Primary
    • 5.3.1. Global Hypertension Drug Market, by Primary, by Region, 2019-2032 (USD Million)
  • 5.4. Secondary
    • 5.4.1. Global Hypertension Drug Market, by Secondary, by Region, 2019-2032 (USD Million)

6. Global Hypertension Drug Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Hypertension Drug Market, by Retail Pharmacies, by Region, 2019-2032 (USD Million)
  • 6.4. E-Commerce Pharmacies
    • 6.4.1. Global Hypertension Drug Market, by E-Commerce Pharmacies, by Region, 2019-2032 (USD Million)
  • 6.5. Hospital Pharmacies
    • 6.5.1. Global Hypertension Drug Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)

7. Global Hypertension Drug Market, by Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • 7.3. Diuretics
    • 7.3.1. Global Hypertension Drug Market, by Diuretics, by Region, 2019-2032 (USD Million)
  • 7.4. Alpha-Blockers
    • 7.4.1. Global Hypertension Drug Market, by Alpha-Blockers, by Region, 2019-2032 (USD Million)
  • 7.5. Calcium Channel Blockers
    • 7.5.1. Global Hypertension Drug Market, by Calcium Channel Blockers, by Region, 2019-2032 (USD Million)
  • 7.6. Beta blockers
    • 7.6.1. Global Hypertension Drug Market, by Beta blockers, by Region, 2019-2032 (USD Million)
  • 7.7. Angiotensin-Converting Enzyme (A.C.E.) Inhibitors
    • 7.7.1. Global Hypertension Drug Market, by Angiotensin-Converting Enzyme (A.C.E.) Inhibitors, by Region, 2019-2032 (USD Million)
  • 7.8. Vasodilators
    • 7.8.1. Global Hypertension Drug Market, by Vasodilators, by Region, 2019-2032 (USD Million)
  • 7.9. Others
    • 7.9.1. Global Other Hypertension Drug Market, by Region, 2019-2032 (USD Million)

8. Global Hypertension Drug Market, by Medication Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • 8.3. Combination Therapy
    • 8.3.1. Global Hypertension Drug Market, by Combination Therapy, by Region, 2019-2032 (USD Million)
  • 8.4. Monotherapy
    • 8.4.1. Global Hypertension Drug Market, by Monotherapy, by Region, 2019-2032 (USD Million)
  • 8.5. Fixed Dose Combinations
    • 8.5.1. Global Hypertension Drug Market, by Fixed Dose Combinations, by Region, 2019-2032 (USD Million)

9. Global Hypertension Drug Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Hypertension Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Hypertension Drug Market - North America
    • 9.3.1. North America: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
    • 9.3.2. North America: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
    • 9.3.3. North America: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.3.4. North America: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.3.5. Hypertension Drug Market - U.S.
      • 9.3.5.1. U.S.: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.3.6. Hypertension Drug Market - Canada
      • 9.3.6.1. Canada: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • 9.4. Hypertension Drug Market - Europe
    • 9.4.1. Europe: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
    • 9.4.2. Europe: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
    • 9.4.3. Europe: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.4. Europe: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.5. Hypertension Drug Market - UK
      • 9.4.5.1. UK: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.6. Hypertension Drug Market - France
      • 9.4.6.1. France: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.6.2. France: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.6.3. France: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.6.4. France: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.7. Hypertension Drug Market - Germany
      • 9.4.7.1. Germany: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.8. Hypertension Drug Market - Italy
      • 9.4.8.1. Italy: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.9. Hypertension Drug Market - Spain
      • 9.4.9.1. Spain: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.10. Hypertension Drug Market - Netherlands
      • 9.4.10.1. Netherlands: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.4.11. Hypertension Drug Market - Russia
      • 9.4.11.1. Russia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • 9.5. Hypertension Drug Market - Asia Pacific
    • 9.5.1. Asia Pacific: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.5. Hypertension Drug Market - China
      • 9.5.5.1. China: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.5.3. China: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.5.4. China: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.6. Hypertension Drug Market - India
      • 9.5.6.1. India: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.6.3. India: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.6.4. India: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.7. Hypertension Drug Market - Japan
      • 9.5.7.1. Japan: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.8. Hypertension Drug Market - Malaysia
      • 9.5.8.1. Malaysia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.9. Hypertension Drug Market - Indonesia
      • 9.5.9.1. Indonesia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.5.10. Hypertension Drug Market - South Korea
      • 9.5.10.1. South Korea: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • 9.6. Hypertension Drug Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.6.5. Hypertension Drug Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.6.6. Hypertension Drug Market - South Africa
      • 9.6.6.1. South Africa: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.6.7. Hypertension Drug Market - Israel
      • 9.6.7.1. Israel: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.6.8. Hypertension Drug Market - UAE
      • 9.6.8.1. UAE: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • 9.7. Hypertension Drug Market - Latin America
    • 9.7.1. Latin America: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.7.5. Hypertension Drug Market - Mexico
      • 9.7.5.1. Mexico: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.7.6. Hypertension Drug Market - Brazil
      • 9.7.6.1. Brazil: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
    • 9.7.7. Hypertension Drug Market - Argentina
      • 9.7.7.1. Argentina: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Hypertension Drug Market, by Type, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Takeda Pharmaceutical Company Limited
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AstraZeneca
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Teva Pharmaceutical Industries Ltd
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Abbott
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Pfizer Inc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Novartis AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Merck KGaA
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Johnson & Johnson Services, Inc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Gilead Sciences, Inc
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Sanofi S.A
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Bayer AG
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development

List of Tables

  • Table 1 Global Hypertension Drug Market, by Condition, by Region, 2019-2032 (USD Million)
  • Table 2 Global Hypertension Drug Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 3 Global Hypertension Drug Market, by Type, by Region, 2019-2032 (USD Million)
  • Table 4 Global Hypertension Drug Market, by Medication Type, by Region, 2019-2032 (USD Million)
  • Table 5 Hypertension Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 7 North America: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 North America: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 9 North America: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 11 U.S.: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 12 U.S.: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 13 U.S.: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 14 Canada: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 15 Canada: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 16 Canada: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 17 Canada: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 18 Europe: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 19 Europe: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 Europe: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 21 Europe: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 22 Germany: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 23 Germany: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 24 Germany: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 25 Germany: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 26 France: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 27 France: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 28 France: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 29 France: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 30 UK: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 31 UK: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 UK: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 33 UK: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 34 Italy: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 35 Italy: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 36 Italy: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 37 Italy: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 38 Netherlands: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 39 Netherlands: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 40 Netherlands: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 41 Netherlands: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 42 Spain: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 43 Spain: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 Spain: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 45 Spain: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 46 Russia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 47 Russia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 48 Russia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 49 Russia: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 54 China: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 55 China: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 China: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 57 China: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 58 Japan: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 59 Japan: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 60 Japan: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 61 Japan: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 62 India: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 63 India: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 64 India: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 65 India: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 66 Indonesia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 67 Indonesia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Indonesia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 69 Indonesia: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 70 Malaysia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 71 Malaysia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 72 Malaysia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 73 Malaysia: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 74 South Korea: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 75 South Korea: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 76 South Korea: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 77 South Korea: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 78 Latin America: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 79 Latin America: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Latin America: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 81 Latin America: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 83 Brazil: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 84 Brazil: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 85 Brazil: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 86 Mexico: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 87 Mexico: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 88 Mexico: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 89 Mexico: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 90 Argentina: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 91 Argentina: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 92 Argentina: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 93 Argentina: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 98 UAE: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 99 UAE: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 100 UAE: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 101 UAE: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 106 South Africa: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 107 South Africa: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 108 South Africa: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 109 South Africa: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)
  • Table 110 Israel: Hypertension Drug Market, by Condition, 2019-2032 (USD Million)
  • Table 111 Israel: Hypertension Drug Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 112 Israel: Hypertension Drug Market, by Type, 2019-2032 (USD Million)
  • Table 113 Israel: Hypertension Drug Market, by Medication Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Hypertension Drug Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Medication Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Condition
  • Figure 7. Global Hypertension Drug Market, by Condition, 2021 & 2030 (USD Million)
  • Figure 8. Market by Medication Type
  • Figure 9. Global Hypertension Drug Market, by Medication Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Hypertension Drug Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 12. Market by Type
  • Figure 13. Global Hypertension Drug Market, by Type, 2021 & 2030 (USD Million)
  • Figure 14. Hypertension Drug Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 15. Strategic Analysis - Hypertension Drug Market